Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:50:56 EDT Sat 14 Jun 2025
Enter Symbol
or Name
USA
CA



Q:CDXC - CHROMADEX CORPORATION - https://www.chromadex.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CDXC - QDEFUNCT7.87    9.18  2.305Mar 18Mar 1315 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-03-13 08:34U:CDXCNews ReleaseChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025
2025-03-11 16:04U:CDXCNews ReleaseChromaDex to Present at the 37th Annual Roth Conference
2025-03-04 16:02U:CDXCNews ReleaseChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 Results
2025-02-25 16:07U:CDXCNews ReleaseChromaDex to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Tuesday, March 4, 2025
2025-01-06 08:32U:CDXCNews ReleaseChromaDex to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
2024-12-03 08:34U:CDXCNews ReleaseChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category
2024-11-14 08:32U:CDXCNews ReleaseChromaDex's Patented Nicotinamide Riboside (NR) Ingredient, Niagen(TM), Featured as the Hero Ingredient in Longevity.Technology's Inaugural Longevity Supplement
2024-11-07 08:32U:CDXCNews ReleaseChromaDex's Pharmaceutical-Grade Niagen(TM) IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide
2024-10-31 16:04U:CDXCNews ReleaseChromaDex Corporation Reports Third Quarter 2024 Financial Results
2024-10-28 08:32U:CDXCNews ReleaseChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
2024-10-24 08:32U:CDXCNews ReleaseChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
2024-10-23 08:34U:CDXCNews ReleaseChromaDex to Participate in the 17th Annual LD Micro Main Event
2024-10-15 08:32U:CDXCNews ReleaseYasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN)
2024-09-26 16:12U:CDXCNews ReleaseChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference
2024-09-20 08:32U:CDXCNews ReleaseChromaDex Appoints Ozan Pamir as Chief Financial Officer
2024-09-10 08:32U:CDXCNews ReleaseChromaDex Announces Expansion of Pharmaceutical-Grade Niagen(TM) IV and Injection Offerings to Additional Leading Wellness Clinics
2024-09-09 08:34U:CDXCNews ReleaseChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions
2024-08-23 08:34U:CDXCNews ReleaseChromaDex to Participate in Renmark's Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024
2024-08-19 08:32U:CDXCNews ReleaseChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+
2024-08-07 16:04U:CDXCNews ReleaseChromaDex Corporation Reports Second Quarter 2024 Financial Results